The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology

被引：63

作者：

Good, J. S. ^{[1
]}

Harrington, K. J. ^{[1
,2
]}

机构：

[1] Royal Marsden Hosp, Head & Neck Unit, London SW3 6JJ, England

[2] Inst Canc Res, Targeted Therapy Lab, London SW3 6JB, England

来源：

CLINICAL ONCOLOGY | 2013年 / 25卷 / 10期

关键词：

Radiobiology; radiosensitivity; redistribution; reoxygenation; repair; repopulation; ENDOTHELIAL GROWTH-FACTOR; IONIZING-RADIATION; DNA-REPAIR; TGF-BETA; CELLS; RADIOTHERAPY; INHIBITION; TELOMERASE; METABOLISM; IRRADIATION;

D O I：

10.1016/j.clon.2013.06.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A comprehensive, mechanistic understanding of radiobiological phenomena that can be integrated within the broader context of cancer biology offers the prospect of transforming clinical practice in radiation oncology. In this review, we revisit the six established biological hallmarks of cancer and examine how they have provided insights into novel therapeutic strategies. In addition, we discuss the potential of two emerging hallmarks to continue to expand our understanding beyond the narrow confines of the traditional 5Rs of radiobiology. (C) 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：569 / 577

页数：9

共 86 条

[31]

Hardee ME, 2012, CANCER RES, V72, P1

[32] Cancer treatments transform residual cancer cell phenotype [J].

Harless, William W. .

CANCER CELL INTERNATIONAL, 2011, 11

[33] Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer [J].

Harrington, K. ;

Jankowska, P. ;

Hingorani, M. .

CLINICAL ONCOLOGY, 2007, 19 (08) :561-571

[34] Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation [J].

Heiden, Matthew G. Vander ;

Cantley, Lewis C. ;

Thompson, Craig B. .

SCIENCE, 2009, 324 (5930) :1029-1033

[35] Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced [J].

Hellevik, Turid ;

Pettersen, Ingvild ;

Berg, Vivian ;

Winberg, Jan Olof ;

Moe, Bjorn T. ;

Bartnes, Kristian ;

Paulssen, Ruth H. ;

Busund, Lill-Tove ;

Bremnes, Roy ;

Chalmers, Anthony ;

Martinez-Zubiaurre, Inigo .

RADIATION ONCOLOGY, 2012, 7

[36] Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors [J].

Hicks, Kevin O. ;

Siim, Bronwyn G. ;

Jaiswal, Jagdish K. ;

Pruijn, Frederik B. ;

Fraser, Annie M. ;

Patel, Rita ;

Hogg, Alison ;

Liyanage, H. D. Sarath ;

Dorie, Mary Jo ;

Brown, J. Martin ;

Denny, William A. ;

Hay, Michael P. ;

Wilson, William R. .

CLINICAL CANCER RESEARCH, 2010, 16 (20) :4946-4957

[37] Lactate: A Metabolic Key Player in Cancer [J].

Hirschhaeuser, Franziska ;

Sattler, Ulrike G. A. ;

Mueller-Klieser, Wolfgang .

CANCER RESEARCH, 2011, 71 (22) :6921-6925

[38] Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma [J].

Hoskin, Peter J. ;

Rojas, Ana M. ;

Bentzen, Soren M. ;

Saunders, Michele I. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) :4912-4918

[39] Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: Comparison with other hypoxia-activated prodrugs [J].

Hunter, Francis W. ;

Wang, Jingli ;

Patel, Rita ;

Hsu, Huai-Ling ;

Hickey, Anthony J. R. ;

Hay, Michael P. ;

Wilson, William R. .

BIOCHEMICAL PHARMACOLOGY, 2012, 83 (05) :574-585

[40] Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial [J].

Janssens, Geert O. ;

Rademakers, Saskia E. ;

Terhaard, Chris H. ;

Doornaert, Patricia A. ;

Bijl, Hendrik P. ;

van den Ende, Piet ;

Chin, Alim ;

Marres, Henri A. ;

de Bree, Remco ;

van der Kogel, Albert J. ;

Hoogsteen, Ilse J. ;

Bussink, Johannes ;

Span, Paul N. ;

Kaanders, Johannes H. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15) :1777-1783

← 1 2 3 4 5 6 7 8 9 →